Meningitis (Nursing) (2024)

Learning Outcome

1. List the causes of meningitis

2. Describe the presentation of meningitis

3. Summarize the treatment of meningitis

4. Recall the nurse management of a patient with meningitis

Introduction

Meningitis is defined as inflammation of the meninges. The meninges are the three membranes (the dura mater, arachnoid mater, and pia mater) that line the vertebral canal and skullenclosing the brain and spinal cord. Encephalitis, on the other hand, is inflammation of the brain itself.[1][2]

Signs and symptoms of meningeal inflammation have been recorded in countless ancient texts throughout history; however, the term 'meningitis' came into general usage after surgeon John Abercrombie defined it in 1828.

Despite breakthroughs in diagnosis, treatment, and vaccination, in 2015, there were 8.7 million reported cases of meningitis worldwide, with 379,000 subsequent deaths.[3][4][5]

Nursing Diagnosis

• Ineffective tissue perfusion related to cerebral edema as evidenced by hypercapnia.

• Hyperthermia related to infection as evidenced by body temperature above the normal range.

• Acute pain related to increased intracranial pressure as evidenced by headache.

• Disturbed sensory perception related to decreased loss of consciousness as evidenced by altered sensorium.

• Anxiety-related to change in the health status of a patient as evidenced by expressed concern and worry about actual hospitalization and seriousness of the illness.

• Deficient knowledge related to lack of exposure to information as evidenced by request for information about medications, signs and symptoms, and behaviors to report.

• The risk for injury related to the internal factors of altered neurologic regulatory function.

• Impaired physical mobility related tointravenous infusion, nuchal rigidity, and restraining devices.

• Interrupted family processes related to the critical nature of the situation and uncertain prognosis.

• Ineffective airway clearancerelated to neuromuscular damage as evidenced by difficulty in breathing.

Causes

Meningitis is a life-threatening disorder that is most often caused by bacteria or viruses. Before the era of antibiotics, the condition was universally fatal. Nevertheless, even with great innovations in healthcare, the condition still carries a mortality rate of close to 25%.

Meningitis can be caused by infectious and non-infectious processes (autoimmune disorders, cancer/paraneoplastic syndromes, drug reactions).

The infectious etiologic agents of meningitis include bacteria, viruses, fungi, and less commonly parasites.

Risk Factors

Risk factors for meningitis include:

• Chronic medical disorders (renal failure, diabetes, adrenal insufficiency, cystic fibrosis)

• Extremes of age

• Undervaccination

• Immunosuppressed states (iatrogenic, transplant recipients, congenital immunodeficiencies, AIDS)

• Living in crowded conditions

• Exposures:

  • Travel to endemic areas (Southwestern U.S. for cocci; Northeastern U.S. for Lyme disease)

  • Vectors (mosquitoes, ticks)

• Alcohol use disorder

• Presence of ventriculoperitoneal (VP) shunt

• Presence of external ventricular drain

• Penetrating head injury

• Lumbar puncture

• Cranial or spinal surgeries involving the opening of the dura

• Bacterial endocarditis

• Malignancy

• Dural defects

• IV drug use

• Sickle cell anemia

• Splenectomy

In theUnited States, the annual incidence of bacterial meningitis isapproximately 1.38 cases/100,000 population with a case fatality rate of 14.3%.[6]

The highest incidence of meningitis worldwide is in an area of sub-Saharan Africa dubbed “the meningitis belt” stretching from Ethiopia to Senegal.[7][4][8]

Most common bacterial causes of meningitis in the United States are:[9]

• Streptococcus pneumoniae(incidence in 2010: 0.3/100,000)

• Group BStreptococcus

• Neisseria meningitis(incidence in 2010: 0.123/100,000)

• Haemophilus influenza(incidence in 2010: 0.058/100,000)

• Listeria monocytogenes

Consider less common bacteria such asStaphylococcus aureusin patients with recent surgery, central lines, and trauma.Mycobacterium tuberculosisshould be considered in immunocompromised hosts.Borrelia burgdorferiin patients with travel to Lyme endemic areas.Treponema pallidumin HIV/AIDS and individuals with multiple sexual partners.Escherichia coliis an important pathogen in the neonatal period.

The most common viral agents of meningitis are non-polio enteroviruses (group b coxsackievirus and echovirus). Other viral causes: mumps, Parechovirus, Herpesviruses (including Epstein Barr virus, Herpes simplex virus, and Varicella-zoster virus), measles, influenza, and arboviruses (West Nile, La Crosse, Powassan, Jamestown Canyon)

Fungal meningitis typicallyis associated with an immunocompromised host (HIV/AIDS, chronic corticosteroid therapy, and patients with cancer).

Fungi causing meningitis include:

• Cryptococcus neoformans

• Coccidioides immitis

• Aspergillus

• Candida

• Mucormycosis (more common in patients with diabetes mellitus and transplant recipients; direct extension of sinus infection)

Assessment

Meningitis can have a varied clinical presentation depending on the age and immune status of the host. Symptoms typically include fever, neck pain/stiffness, and photophobia. More non-specific symptoms include headache, dizziness, confusion, delirium, irritability, and nausea/vomiting. Signs of increased intracranial pressure (altered mental status, neurologic deficits, and seizures) portend a poor prognosis.

The following risk factors should increase clinical suspicion:

• Close contact exposures (military barracks, college dorms)

• Incomplete vaccinations

• Immunosuppression

  See Also

  What is an ER Nurse?Nurses in Disaster Preparedness and Public Health Emergency ResponseShock in Pediatrics Clinical Presentation: History, Physical ExaminationNursing guidelines : Nursing Management of Meningitis

• Children younger than five years and adults older than 65 years

• Alcohol use disorder

One should try to determine a history of exposures, sexual contact, animal contact, previous neurosurgical intervention, recent travel, head injury, and the season. Most viral cases tend to occur in the warmer months.

In adults, the physical exam is centered on identifying focal neurologic deficits, meningeal irritation (Brudzinski and Kernig signs), and particularly in meningococcal meningitis, characteristic skin lesions (petechiae and purpura). Cranial nerve abnormalities are seen in 10%-20% of patients.

Signs and symptoms are less evident in neonates and infants. They can present with and without fever or hypothermia, decreased oral intake, altered mental status, irritability, bulging fontanelle. It is important to obtain a full perinatal history and vaccine records. Some causes of meningitis are vaccine-preventable such as Pneumococcus,Haemophilus influenzatype B, Meningococcus, Measles, and Varicella-virus.

Evaluation

Meningitis is diagnosed through cerebrospinal fluid (CSF) analysis, which includes white blood cell count, glucose, protein, culture, and in some cases, polymerase chain reaction (PCR). CSF is obtained via a lumbar puncture (LP), and the opening pressure can be measured.[10][11][12]

Additional testing should be performed tailored on suspected etiology:

• Viral: Multiplex and specific PCRs

• Fungal: CSF fungal culture, India ink stain forCryptococcus

• Mycobacterial: CSF Acid-fast bacilli smear and culture

• Syphilis: CSF VDRL

• Lyme disease: CSFburgdorferiantibody

The CSF findings expected in bacterial, viral, and fungal meningitis are listed in the chart: Expected CSF findings in bacterial versus viral versus fungal meningitis.

Ideally, the CSF sample should be obtained before initiating antimicrobials. However, when the diagnosis of bacterial meningitis is seriously considered, and the patient is severely ill, antibiotics should be initiated before performing the LP.

Computed Tomography (CT) of the Head before Lumbar Puncture

There is controversy regarding the adage that the lumbar puncture is the inciting event causing brain herniation and death in the setting of increased intracranial pressure caused by acute bacterial meningitis.

Currently, guidelines recommend empiric antibiotics and supportive care, while forgoing the lumbar puncture if there is clinical suspicion of increased intracranial pressure or impending brain herniation.

Signs and symptoms of impending herniation include:

• Glasgow coma scale (GCS) less than 11

• Lethargy

• Altered mental status

• New-onset seizures

• Focal neurologic deficit

It is important to note thata normal head CT does not preclude increased intracranial pressure or impending brain herniation. If the clinical symptoms are consistent with impending herniation, regardless of whether or not the CT head is normal, avoid the LP and start treatment.

Blood work should include blood culture, serum electrolytes as the syndrome of inappropriate antidiuretic hormone secretion (SIADH)is not uncommon, serum glucose, renal and liver function, and testing for HIV.

Medical Management

Antibiotics and supportive care are critical in all cases of bacterial meningitis.[13][14][15]

Managing the airway, maintaining oxygenation, giving sufficient intravenous fluids while providing fever control are parts of the foundation of meningitis management.

The type of antibiotic is based on the presumed organism causing the infection. The clinician must take into account patient demographics and past medical history in order to provide the best antimicrobial coverage.

Current Empiric Therapy

Neonates -Up to 1 month old

• Ampicillin intravenously (IV) and

• Cefotaxime (or equivalent, usually ceftazidime or cefepime) IV or gentamicin IV and

• Acyclovir IV

More than 1 month old

• Ampicillin IV and

• Ceftriaxone IV

Adults (18 to 49 years old)

• Ceftriaxone IV and

• Vancomycin IV

Adults older than 50 years old and the immunocompromised

• Ceftriaxone IV and

• Vancomycin IV and

• Ampicillin IV

Meningitis associated with a foreign body (post-procedure, penetrating trauma)

• Cefepime IV or ceftazidime IV or meropenem IV and

• Vancomycin IV

Meningitis with severe penicillin allergy

• Moxifloxacin IV and

• Vancomycin IV

Fungal (Cryptococcal) meningitis

• Amphotericin B IV and

• Flucytosine by mouth

Antibiotics

Ceftriaxone

• Third-generation cephalosporin

• Gram-negative coverage

• Very effective againstStreptococcus pneumoniaeandNeisseria meningitis

• Better CNS penetration than piperacillin-tazobactam (typically used in gram-negative sepsis coverage)

Vancomycin

• Gram-positive coverage (MRSA)

• Also used for resistant pneumococcus

Ampicillin

• Listeria coverage (gram-positive bacilli)

Cefepime

• Fourth-generation cephalosporin

• Increased activity against pseudomonas

Cefotaxime

• Third-generation cephalosporin

  See Also

  8. Recognition of Child Abuse Indicators

• Equivalent to ceftriaxone

• Safe for neonates

Steroid Therapy

There is insufficient evidence to support the widespread use of steroids in bacterial meningitis. Some studies report a reduction in mortality forStreptococcus pneumoniaemeningitis, but not inHaemophilus influenzaorNeisseria meningitidesmeningitis. In children, steroids were associated with a reduction of severe hearing impairment only in cases ofHaemophilus influenzameningitis.[16]

Increased Intracranial Pressure

If the patient develops clinical signs of increased intracranial pressure (altered mental status, neurologic deficits, non-reactive pupils, bradycardia), interventions to maintain cerebral perfusion include:

• Elevating the head of the bed to 30 degrees

• Inducing mild hyperventilation in the intubated patient

• Osmotic diuretics such as 25% mannitol or 3% saline

Chemoprophylaxis

Chemoprophylaxis is indicated for close contacts of a patient diagnosed withN. meningitidesandH. influenzaetype B meningitis.

Close contacts include housemates, significant others, those who have shared utensils, and health care providers in proximity to secretions (providing mouth-to-mouth resuscitation, intubating without a facemask).

Antibiotic chemoprophylaxis forN. meningitidisincludes rifampin, ciprofloxacin, or ceftriaxone, and forH. influenzaetype B: rifampin.

Nursing Management

• Monitoring and recording vital signs.

• Assess the Glasgow Coma Scale and pay special attention to the motor response, immediately inform the on-duty doctor if it falls.

• Assess the patient's mental status and provide psychological support if the patient is conscious.

• Elevate the head of the bed to 30 degrees with a straight neck for venous drainage from the brain.

• Ensure the patient has an IV line for fluids and medications.

• Administer antibiotics as prescribed.

• Offer oxygenation if the saturation level is low.

• Administer mannitol, as prescribed, if the intracranial pressure is high.

• Administer phenytoin, as prescribed, if the patient is having seizures.

• Apply side rails as apatient safety measure as the patient may fall down while having seizures.

• Check pupils size and responsiveness to light (think elevated intracranial pressure)

• Assess hearing power in both ears.

• Check labs (meningitis may cause SIADH)

• Check renal and liver function tests.

• Check cerebrospinal fluid lab results.

• Change position every 2-hourly to preventbedsore if the patient is bedridden and apply air mattress and thromboembolic deterrent stockings as needed)

• Provide limb physio and chest physio to prevent the complications associated with immobility.

• Never forget to measure random blood sugarbefore lumbar puncture while sending CSF for a glucose test.

• A proper diet chart to provide adequate calories required for the body.

• Put a nasogastric tube and start feeding for the unconscious patients, as instructed

• Monitor intake and output.

• Provide comfort measures.

When To Seek Help

• If unresponsive

• High-grade fever

• New mental status changes

• Hypotension

• Hypoxia

• Bradycardia

• Seizures

• Severe headache

Outcome Identification

For patients treated promptly, the prognosis is good. However, patients who present with an altered state of consciousness have high morbidity and mortality. Some patients may develop seizuresduring the illness, which are very difficult to control or are prolonged. Any patient with a residual neurological deficit after meningitis treatment is also left with a disability. Patients art the greatest risk for death usually have thefollowing features:

• Advanced aged

• Low Glasgow coma scale

• CSF WBC count which is low

• Tachycardia

• Gram-positivecocci in the CSF

Serious complications in survivors include:

• Ataxia

• Hearing loss

• Cranial nerve palsies

• Cognitive dysfunction

• Cortical blindness

• Hydrocephalus

• Seizures

• Focal paralysis

The mortality is highest for children less than 12 months of age and decreases in middle age. However, the mortality rates increase with advancing age. Overall, 10% of patients willdie from bacterial meningitis. The mortality is highest when the infection is caused by streptococcus and listeria. Patients with meningococcal meningitis do respond well to treatment, but if the presentation is late with meningococcemia, the mortality rates are nearly 30%.[17][18][19] [Level 2]

Monitoring

• Vital signs

• Glasgow Coma Scale score

• Check the dose and timing of medications

• Dietary pattern

Coordination of Care

Meningitis is a serious disorder with high morbidity and mortality. The majority of patients with meningitis first present to the emergency department and a streamlined interprofessional approach is vital if one wants to lower the high morbidity. The triage nurse must be fully aware of the signs and symptoms of the illness and refer the patient immediately to the emergency department clinician. Other specialists who are usually involved in the care of these patients are neurologists, pediatricians, intensivists, infectious disease specialists, and pharmacists. If bacterial meningitis is suspected, prompt antibiotics should be started even in the absence of laboratory results. The pharmacist, preferably specializing in infectious diseases, should assist the clinical team in choosing the appropriate antibiotics based on the age of the patient and local sensitivities and correct dosing to ensure penetration into the central nervous system.

To prevent this infection, the education of the public is vital. All healthcare workers (nurses, physicians, and pharmacists) should educate patients and parents in regards to vaccine-preventable meningitis (H. influenzaetype B,S. pneumoniae,N. meningitidis, Measles, and Varicella). Across the board, the incidence of meningitis has decreased with the implementation of generalized vaccination. Family members should be educated about the need for prophylaxis when there is a family member withNeisseriaandH. influenzaetype B meningitis. All contacts should be educated about the signs and symptoms of the infection and when to return to the emergency department.[20]

Health Teaching and Health Promotion

The nurse should educate the parents on ensuring that the children are vaccinated againstN. meningitides. The pharmacist should also educate the family about the need for prophylaxis when there is a family member with Neisseria meningitis. All contacts should be educated about the signs and symptoms of the infection and when to return to the emergency department.[20][Level 1]

Educatefamily members to provide a nutritional diet that contains more antioxidants, omega 3 fatty acids, and probiotics which allow for better nutritional absorption and citrus fruits to boost the immune system.

Encourage to maintain the personal hygiene of the patient.

Never leave the patient alone to prevent any fall injury due to seizure.

Patients should avoid driving vehicles, if instructed to do so by the doctor, as some of them may have blurred vision.

Educate about the techniques of nasogastric tube feeding to the family member who may have to take care of an unconscious patient.

Risk Management

Meningitis is a serious disorder with very high morbidity and mortality. The majority of patients with meningitis first present to the emergency department and a streamlined interprofessional approach is vital if one wants to lower the high morbidity. The triage nurse must be fully aware of the signs and symptoms of the illness and refer the patient immediately to the physician. Other specialists who are usually involved in the care of these patients are neurologists, pediatricians, intensivists, infectious disease specialists, and pharmacists. If bacterial meningitis is suspected, prompt antibiotics should be started even in the absence of laboratory results. To prevent this infection, the education of the public is vital.

Discharge Planning

After hospitalization, the patient at home should:

• Activities.Alternate rest and activity to conserve energy.

• Asepsis.Promote simple home infection control procedures.

• Infectious process.Identify signs and symptoms of an infectious process and report promptly to the provider.

• Diet.Consume safe and healthy foods. Avoid drinking alcohol and smoking.

• Should not climb high altitudes.

• Be in the vicinity of family members

• Report immediately to any near ones if any discomfort in the health status.

• Never skip any medications unless advised to do so.

Pearls and Other issues

Differentiating between bacterial, viral, and fungal meningitis may be difficult. CSF analysis may not be conclusive, and cultures do not immediately yield an answer. Given the morbidity and mortality, it is prudent to initiate empiric antibiotic therapy and admit all those with suspected meningitis to the hospital on droplet precautions.

Review Questions

• Access free multiple choice questions on this topic.

• Comment on this article.

References

1.

Chalimou I, Krilis A, Anastopoulou GG, Braun H, Vikelis M, Makridou A, Makris N, Argyriou AA. Acute aseptic meningitis during isotretinoin treatment for nodular acne solely presenting with headache: case report and brief review of the literature. Int J Neurosci. 2019 Feb;129(2):204-206. [PubMed: 30160569]

2.

Ali M, Chang BA, Johnson KW, Morris SK. Incidence and aetiology of bacterial meningitis among children aged 1-59 months in South Asia: systematic review and meta-analysis. Vaccine. 2018 Sep 18;36(39):5846-5857. [PubMed: 30145101]

3.

Giovane RA, Lavender PD. Central Nervous System Infections. Prim Care. 2018 Sep;45(3):505-518. [PubMed: 30115337]

4.

Leonard A, Lalk M. Infection and metabolism - Streptococcus pneumoniae metabolism facing the host environment. Cytokine. 2018 Dec;112:75-86. [PubMed: 30077545]

5.

Kasim N, Bagga B, Diaz-Thomas A. Intracranial pathologies associated with central diabetes insipidus in infants. J Pediatr Endocrinol Metab. 2018 Sep 25;31(9):951-958. [PubMed: 30052518]

6.

Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, Harrison LH, Farley MM, Reingold A, Bennett NM, Craig AS, Schaffner W, Thomas A, Lewis MM, Scallan E, Schuchat A., Emerging Infections Programs Network. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011 May 26;364(21):2016-25. [PubMed: 21612470]

7.

Sadeghi M, Ahmadrajabi R, Dehesh T, Saffari F. Prevalence of meningococcal carriage among male university students living in dormitories in Kerman, southeast of Iran. Pathog Glob Health. 2018 Sep;112(6):329-333. [PMC free article: PMC6381525] [PubMed: 30156971]

8.

Chauhan D, Mokta K, Kanga A, Grover N. Epidemiology, clinical profile and role of rapid tests in the diagnosis of acute bacterial meningitis in children (aged 1-59 months). Neurol India. 2018 Jul-Aug;66(4):1045-1049. [PubMed: 30038091]

9.

Castelblanco RL, Lee M, Hasbun R. Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. Lancet Infect Dis. 2014 Sep;14(9):813-9. [PubMed: 25104307]

10.

Güldemir D, Turan M, Bakkaloğlu Z, Nar Ötgün S, Durmaz R. [Optimization of real-time multiplex polymerase chain reaction for the diagnosis of acute bacterial meningitis and Neisseria meningitidis serogrouping]. Mikrobiyol Bul. 2018 Jul;52(3):221-232. [PubMed: 30156509]

11.

Hussien MM, Ali-Eldin F, Adel LA. ASSESSMENT OF THE DIAGNOSTIC AND PROGNOSTIC ROLE OF CEREBEROSPINAL FLUID INTERLEUKIN-8 LEVEL IN ADULT PATIENTS WITH MENINGITIS. J Egypt Soc Parasitol. 2016 Aug;46(2):361-366. [PubMed: 30152945]

12.

El Shorbagy HH, Barseem NF, Abdelghani WE, Suliman HA, Al-Shokary AH, Elsadek AE, Maksoud YHA, Sabri JH. The value of serum procalcitonin in acute meningitis in children. J Clin Neurosci. 2018 Oct;56:28-33. [PubMed: 30143413]

13.

Reid S, Thompson H, Thakur KT. Nervous System Infections and the Global Traveler. Semin Neurol. 2018 Apr;38(2):247-262. [PubMed: 29791951]

14.

Liu ZY, Wang GQ, Zhu LP, Lyu XJ, Zhang QQ, Yu YS, Zhou ZH, Liu YB, Cai WP, Li RY, Zhang WH, Zhang FJ, Wu H, Xu YC, Lu HZ, Li TS., Society of Infectious Diseases, Chinese Medical Association. [Expert consensus on the diagnosis and treatment of cryptococcal meningitis]. Zhonghua Nei Ke Za Zhi. 2018 May 01;57(5):317-323. [PubMed: 29747285]

15.

Dretler AW, Rouphael NG, Stephens DS. Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. Hum Vaccin Immunother. 2018 May 04;14(5):1146-1160. [PMC free article: PMC6067816] [PubMed: 29543582]

16.

Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;2015(9):CD004405. [PMC free article: PMC6491272] [PubMed: 26362566]

17.

Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010 May;10(5):317-28. [PubMed: 20417414]

18.

Munguambe AM, de Almeida AECC, Nhantumbo AA, Come CE, Zimba TF, Paulo Langa J, de Filippis I, Gudo ES. Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis. PLoS One. 2018;13(8):e0197390. [PMC free article: PMC6082507] [PubMed: 30089105]

Disclosure: Kenadeed Hersi declares no relevant financial relationships with ineligible companies.

Disclosure: Francisco Gonzalez declares no relevant financial relationships with ineligible companies.

Disclosure: Noah Kondamudi declares no relevant financial relationships with ineligible companies.

Disclosure: Rashmi Sapkota declares no relevant financial relationships with ineligible companies.